C

PriceCrinetics Pharmaceuticals

CRNX

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Historical stock price chart and annual return over the past years

97%

5 years

% Total

CRNX
15%

5 years

Annual Return

CRNX